248 related articles for article (PubMed ID: 23401506)
1. Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells.
Tsai S; Serra P; Clemente-Casares X; Yamanouchi J; Thiessen S; Slattery RM; Elliott JF; Santamaria P
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3471-6. PubMed ID: 23401506
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-dependent in vivo generation of autoregulatory T cells by antidiabetogenic MHC class II.
Tsai S; Serra P; Clemente-Casares X; Slattery RM; Santamaria P
J Immunol; 2013 Jul; 191(1):70-82. PubMed ID: 23740949
[TBL] [Abstract][Full Text] [Related]
3. T-cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetes.
Thiessen S; Serra P; Amrani A; Verdaguer J; Santamaria P
Diabetes; 2002 Feb; 51(2):325-38. PubMed ID: 11812739
[TBL] [Abstract][Full Text] [Related]
4. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
5. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
6. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
7. Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.
Li L; Yi Z; Wang B; Tisch R
J Immunol; 2009 Oct; 183(7):4809-16. PubMed ID: 19752238
[TBL] [Abstract][Full Text] [Related]
8. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
9. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
Schmidt D; Verdaguer J; Averill N; Santamaria P
J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
[TBL] [Abstract][Full Text] [Related]
10. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
[TBL] [Abstract][Full Text] [Related]
11. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
12. Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.
Yamanouchi J; Puertas MC; Verdaguer J; Lyons PA; Rainbow DB; Chamberlain G; Hunter KM; Peterson LB; Wicker LS; Santamaria P
Diabetes; 2010 Jan; 59(1):272-81. PubMed ID: 19833887
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.
Lühder F; Katz J; Benoist C; Mathis D
J Exp Med; 1998 Feb; 187(3):379-87. PubMed ID: 9449718
[TBL] [Abstract][Full Text] [Related]
14. Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes.
Mellanby RJ; Koonce CH; Monti A; Phillips JM; Cooke A; Bikoff EK
J Immunol; 2006 Dec; 177(11):7588-98. PubMed ID: 17114428
[TBL] [Abstract][Full Text] [Related]
15. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.
Price JD; Beauchamp NM; Rahir G; Zhao Y; Rieger CC; Lau-Kilby AW; Tarbell KV
J Leukoc Biol; 2014 Feb; 95(2):325-36. PubMed ID: 24082013
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
[TBL] [Abstract][Full Text] [Related]
17. Relative resistance to nasally induced tolerance in non-obese diabetic mice but not other I-A(g7)-expressing mouse strains.
Quinn A; Melo M; Ethell D; Sercarz EE
Int Immunol; 2001 Oct; 13(10):1321-33. PubMed ID: 11581177
[TBL] [Abstract][Full Text] [Related]
18. Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes.
Besin G; Gaudreau S; Ménard M; Guindi C; Dupuis G; Amrani A
Diabetes; 2008 Aug; 57(8):2107-17. PubMed ID: 18477807
[TBL] [Abstract][Full Text] [Related]
19. Elucidating the Role of Ezh2 in Tolerogenic Function of NOD Bone Marrow-Derived Dendritic Cells Expressing Constitutively Active Stat5b.
Zerif E; Khan FU; Raki AA; Lullier V; Gris D; Dupuis G; Amrani A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899608
[TBL] [Abstract][Full Text] [Related]
20. Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope.
Daniel C; Weigmann B; Bronson R; von Boehmer H
J Exp Med; 2011 Jul; 208(7):1501-10. PubMed ID: 21690251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
